Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cleon Capital is a private investment and advisory firm focused on providing flexible capital solutions and corporate development support to small and mid-sized companies, primarily in Southern Europe. The firm describes its offering as combining equity and hybrid capital investments with hands-on support for build-ups, roll-outs, internationalization, operational improvement, succession planning, and balance-sheet restructuring. Its portfolio spans multiple sectors rather than being dedicated to biotech or healthcare, although it has invested in some life sciences-related businesses such as Algenex, Cocoon Bioscience, and Labomar. Based on publicly available information, Cleon Capital is best characterized as a generalist lower-middle-market private equity/investment platform rather than an operating life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cleon Capital.